Skip to content
★ Sign in to follow
JM
Total declarations
23
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (21 ops.)
€1.1M

Latest filing published 02 Feb 2016 for Travere Therapeutics, Inc..

Insider track record

Disclosed buys
0
Disclosed sells
21
Signal history

No signal scores available.

Jensen Margaret E. Valeur: trading record in brief

This profile gathers the share dealings of Jensen Margaret E. Valeur across 2 companies, led by Neurocrine Biosciences Inc and Travere Therapeutics, Inc. Over a trading history stretching from 12 February 2008 to 1 February 2016, the count stands at 23 filings.

Every open-market trade on record is a sale: 21 sales worth €1.1M. Besides market trades, the filings include 2 share grants.

Most recently, on 2 February 2016, the filings show a share grant in Travere Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Jensen Margaret E. Valeur

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations21 total

21 of 21 declarations